{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:47:02Z","timestamp":1782456422308,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"High-level Talents Project of Affiliated Hospital of Shandong University of Traditional Chinese Medicine","award":["No. rc0000002-41"],"award-info":[{"award-number":["No. rc0000002-41"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["No. ZR2023LZY002"],"award-info":[{"award-number":["No. ZR2023LZY002"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical and Health Technology Development Plan of Shandong Province","award":["No. 202003041150"],"award-info":[{"award-number":["No. 202003041150"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82104609"],"award-info":[{"award-number":["No. 82104609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05455-6","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:48:19Z","timestamp":1782136099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genome-wide investigation of differentially expressed alternative splicing and RNA-binding protein genes association with AML drug resistance"],"prefix":"10.1007","volume":"17","author":[{"given":"Yu-Mei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Min","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"17","key":"5455_CR1","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1182\/blood.2022017333","volume":"141","author":"SK Tahir","year":"2023","unstructured":"Tahir SK, Calvo E. Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia. Blood. 2023;141(17):2114\u201326.","journal-title":"Blood"},{"issue":"6","key":"5455_CR2","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","volume":"28","author":"AGX Zeng","year":"2022","unstructured":"Zeng AGX, Bansal S, Jin L, Mitchell A, Chen WC, Abbas HA, et al. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia. Nat Med. 2022;28(6):1212\u201323.","journal-title":"Nat Med"},{"issue":"1","key":"5455_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","volume":"36","author":"S Tettamanti","year":"2022","unstructured":"Tettamanti S, Pievani A, Biondi A, Dotti G, Serafini M. Catch me if you can: how AML and its niche escape immunotherapy. Leukemia. 2022;36(1):13\u201322.","journal-title":"Leukemia"},{"issue":"1","key":"5455_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","volume":"14","author":"H Liu","year":"2021","unstructured":"Liu H. Emerging agents and regimens for AML. J Hematol Oncol. 2021;14(1):49.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"5455_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-020-00908-z","volume":"13","author":"M Yi","year":"2020","unstructured":"Yi M, Li A, Zhou L, Chu Q, Song Y, Wu K. The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017. J Hematol Oncol. 2020;13(1):72.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"5455_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian H, Kadia T. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 2021;11(2):41.","journal-title":"Blood Cancer J"},{"issue":"3","key":"5455_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98(3):502\u201326.","journal-title":"Am J Hematol"},{"key":"5455_CR8","doi-asserted-by":"publisher","first-page":"656218","DOI":"10.3389\/fonc.2021.656218","volume":"11","author":"A Isidori","year":"2021","unstructured":"Isidori A, Cerchione C, Daver N, DiNardo C, Garcia-Manero G, Konopleva M, et al. Immunotherapy in Acute Myeloid Leukemia: Where We Stand. Front Oncol. 2021;11:656218.","journal-title":"Front Oncol"},{"issue":"1","key":"5455_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12935-021-01746-w","volume":"21","author":"M Levin","year":"2021","unstructured":"Levin M, Stark M, Ofran Y, Assaraf YG. Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance. Cancer Cell Int. 2021;21(1):53.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"5455_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12915-023-01724-w","volume":"21","author":"SH Dam","year":"2023","unstructured":"Dam SH, Olsen LR, Vitting-Seerup K. Expression and splicing mediate distinct biological signals. BMC Biol. 2023;21(1):220.","journal-title":"BMC Biol"},{"key":"5455_CR11","doi-asserted-by":"publisher","first-page":"145523","DOI":"10.1016\/j.gene.2021.145523","volume":"782","author":"KK Kolathur","year":"2021","unstructured":"Kolathur KK. Role of promoters in regulating alternative splicing. Gene. 2021;782:145523.","journal-title":"Gene"},{"key":"5455_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.csbj.2020.12.009","volume":"19","author":"W Jiang","year":"2021","unstructured":"Jiang W, Chen L. Alternative splicing: Human disease and quantitative analysis from high-throughput sequencing. Comput Struct Biotechnol J. 2021;19:183\u201395.","journal-title":"Comput Struct Biotechnol J"},{"issue":"8","key":"5455_CR13","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41375-023-01963-4","volume":"37","author":"ML Morales","year":"2023","unstructured":"Morales ML, Garc\u00eda-Vicente R. Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia. Leukemia. 2023;37(8):1649\u201359.","journal-title":"Leukemia"},{"issue":"8","key":"5455_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.trecan.2020.04.011","volume":"6","author":"E Wang","year":"2020","unstructured":"Wang E, Aifantis I. RNA Splicing and Cancer. Trends Cancer. 2020;6(8):631\u201344.","journal-title":"Trends Cancer"},{"issue":"1","key":"5455_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-020-00927-w","volume":"13","author":"H Qin","year":"2020","unstructured":"Qin H, Ni H, Liu Y, Yuan Y, Xi T. RNA-binding proteins in tumor progression. J Hematol Oncol. 2020;13(1):90.","journal-title":"J Hematol Oncol"},{"issue":"18","key":"5455_CR16","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1182\/blood.2019000802","volume":"134","author":"YM Sun","year":"2019","unstructured":"Sun YM, Wang WT, Zeng ZC, Chen TQ, Han C, Pan Q, et al. circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression. Blood. 2019;134(18):1533\u201346.","journal-title":"Blood"},{"issue":"1","key":"5455_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1182\/blood.2023020672","volume":"142","author":"DJ Hodson","year":"2023","unstructured":"Hodson DJ. Breaking the loop in AML. Blood. 2023;142(1):6\u20137.","journal-title":"Blood"},{"issue":"1","key":"5455_CR18","first-page":"90","volume":"142","author":"S Bamezai","year":"2023","unstructured":"Bamezai S, Pulikkottil AJ. A noncanonical enzymatic function of PIWIL4 maintains genomic integrity and leukemic growth in AML. Blood. 2023;142(1):90\u2013105.","journal-title":"Blood"},{"key":"5455_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-1-0716-1795-3_4","volume":"2391","author":"N Gill","year":"2022","unstructured":"Gill N, Dhillon B. RNA-seq Data Analysis for Differential Expression. Methods Mol Biol. 2022;2391:45\u201354.","journal-title":"Methods Mol Biol"},{"key":"5455_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28:511\u20135.","journal-title":"Nat Biotechnol"},{"key":"5455_CR21","doi-asserted-by":"publisher","unstructured":"Liu S, Wang Z, Zhu R, Wang F, Cheng Y, Liu Y. Three differential expression analysis methods for RNA sequencing: Limma, EdgeR, DESeq2. J Vis Exp. 2021. https:\/\/doi.org\/10.3791\/62528","DOI":"10.3791\/62528"},{"key":"5455_CR22","doi-asserted-by":"publisher","first-page":"112537","DOI":"10.1016\/j.biopha.2021.112537","volume":"146","author":"S Nomiri","year":"2022","unstructured":"Nomiri S, Karami H, Baradaran B, Javadrashid D, Derakhshani A, Nourbakhsh NS, et al. Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: A hypothesis based on the weighted gene co-expression network analysis. Biomed Pharmacother. 2022;146:112537.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5455_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12864-017-3507-y","volume":"18","author":"L Jin","year":"2017","unstructured":"Jin L, Li G, Yu D, Huang W, Cheng C, Liao S, et al. Transcriptome analysis reveals the complexity of alternative splicing regulation in the fungus Verticillium dahliae. BMC Genomics. 2017;18(1):130.","journal-title":"BMC Genomics"},{"issue":"6","key":"5455_CR24","doi-asserted-by":"publisher","first-page":"108159","DOI":"10.1016\/j.jdiacomp.2022.108159","volume":"36","author":"K Wang","year":"2022","unstructured":"Wang K, Li L, Jin J, An Y, Wang Z, Zhou S, et al. Fatty acid synthase (Fasn) inhibits the expression levels of immune response genes via alteration of alternative splicing in islet cells. J Diabetes Complications. 2022;36(6):108159.","journal-title":"J Diabetes Complications"},{"issue":"W1","key":"5455_CR25","doi-asserted-by":"publisher","first-page":"W317","DOI":"10.1093\/nar\/gkab447","volume":"49","author":"D Bu","year":"2021","unstructured":"Bu D, Luo H, Huo P, Wang Z, Zhang S, He Z, et al. KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis. Nucleic Acids Res. 2021;49(W1):W317\u201325.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"5455_CR26","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa M, Furumichi M, Sato Y, Matsuura Y, Ishiguro-Watanabe M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 2025;53(D1):672\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"5455_CR27","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28(11):1947\u201351.","journal-title":"Protein Sci"},{"issue":"1","key":"5455_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"5455_CR29","doi-asserted-by":"publisher","first-page":"10040","DOI":"10.3390\/ijms221810040","volume":"22","author":"A Hindley","year":"2021","unstructured":"Hindley A, Catherwood MA, McMullin MF, Mills KI. Significance of NPM1 Gene Mutations in AML. Int J Mol Sci. 2021;22(18):10040.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5455_CR30","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1073\/pnas.1918611117","volume":"117","author":"S Ketkar","year":"2020","unstructured":"Ketkar S, Verdoni AM, Smith AM, Bangert CV, Leight ER, Chen DY, et al. Remethylation of Dnmt3a(-\/-) hematopoietic cells is associated with partial correction of gene dysregulation and reduced myeloid skewing. Proc Natl Acad Sci USA. 2020;117(6):3123\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"5455_CR31","doi-asserted-by":"publisher","first-page":"8505","DOI":"10.3390\/ijms21228505","volume":"21","author":"C Gurnari","year":"2020","unstructured":"Gurnari C, Pagliuca S, Visconte V. Deciphering the Therapeutic Resistance in Acute Myeloid Leukemia. Int J Mol Sci. 2020;21(22):8505.","journal-title":"Int J Mol Sci"},{"key":"5455_CR32","doi-asserted-by":"publisher","first-page":"926296","DOI":"10.3389\/fonc.2022.926296","volume":"12","author":"B Zhang","year":"2022","unstructured":"Zhang B, Li D, Wang R. Transcriptome Profiling of N7-Methylguanosine Modification of Messenger RNA in Drug-Resistant Acute Myeloid Leukemia. Front Oncol. 2022;12:926296.","journal-title":"Front Oncol"},{"key":"5455_CR33","doi-asserted-by":"publisher","first-page":"833694","DOI":"10.3389\/fgene.2022.833694","volume":"13","author":"S Fang","year":"2022","unstructured":"Fang S, Peng B, Wen Y, Yang J, Wang H, Wang Z, et al. Transcriptome-Wide Analysis of RNA N(6)-Methyladenosine Modification in Adriamycin-Resistant Acute Myeloid Leukemia Cells. Front Genet. 2022;13:833694.","journal-title":"Front Genet"},{"issue":"6","key":"5455_CR34","first-page":"e400","volume":"10","author":"B Molina","year":"2021","unstructured":"Molina B, Chavez J. Zebrafish models of acute leukemias: Current models and future directions. Rev Dev Biol. 2021;10(6):e400.","journal-title":"Rev Dev Biol"},{"issue":"Pt1","key":"5455_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.semcancer.2019.08.027","volume":"67","author":"CS Moreno","year":"2020","unstructured":"Moreno CS. SOX4: The unappreciated oncogene. Semin Cancer Biol. 2020;67(Pt1):57\u201364.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"5455_CR36","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/ddr.21837","volume":"82","author":"X He","year":"2021","unstructured":"He X, Zou H, Wang F. SOX4-induced upregulation of ARHGAP9 promotes the progression of acute myeloid leukemia. Drug Dev Res. 2021;82(8):1227\u201334.","journal-title":"Drug Dev Res"},{"issue":"1","key":"5455_CR37","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12967-022-03589-z","volume":"20","author":"T Zhang","year":"2022","unstructured":"Zhang T, Fang Q, Liu P, Wang P, Feng C, Wang J. Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48. J Transl Med. 2022;20(1):394.","journal-title":"J Transl Med"},{"issue":"2","key":"5455_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1042\/CS20191170","volume":"134","author":"Z Wang","year":"2020","unstructured":"Wang Z, Xiao Y, Guan W, Wang M, Chen J, Zhang L, et al. Acute myeloid leukemia immune escape by epigenetic CD48 silencing. Clin Sci. 2020;134(2):261\u201371.","journal-title":"Clin Sci"},{"issue":"5","key":"5455_CR39","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1080\/10428194.2021.2008381","volume":"63","author":"T Qin","year":"2022","unstructured":"Qin T, Cheng Y, Wang X. RNA-binding proteins as drivers of AML and novel therapeutic targets. Leuk Lymphoma. 2022;63(5):1045\u201357.","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"5455_CR40","first-page":"e1592","volume":"5","author":"Z Liu","year":"2021","unstructured":"Liu Z, Spiegelman VS, Wang HG. Distinct noncoding RNAs and RNA binding proteins associated with high-risk pediatric and adult acute myeloid leukemias detected by regulatory network analysis. Cancer Rep. 2021;5(10):e1592.","journal-title":"Cancer Rep"},{"key":"5455_CR41","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3389\/fonc.2019.00692","volume":"9","author":"S Saha","year":"2019","unstructured":"Saha S, Murmu KC, Biswas M, Chakraborty S, Basu J, Madhulika S, et al. Transcriptomic Analysis Identifies RNA Binding Proteins as Putative Regulators of Myelopoiesis and Leukemia. Front Oncol. 2019;9:692.","journal-title":"Front Oncol"},{"issue":"2","key":"5455_CR42","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.molcel.2019.09.017","volume":"76","author":"J Ule","year":"2019","unstructured":"Ule J, Blencowe BJ. Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution. Mol Cell. 2019;76(2):329\u201345.","journal-title":"Mol Cell"},{"key":"5455_CR43","doi-asserted-by":"publisher","first-page":"778637","DOI":"10.3389\/fonc.2021.778637","volume":"11","author":"L Zhu","year":"2021","unstructured":"Zhu L, Wang Z, Sun Y, Giamas G, Stebbing J, Yu Z, et al. A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma. Front Oncol. 2021;11:778637.","journal-title":"Front Oncol"},{"issue":"1","key":"5455_CR44","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1186\/s12885-021-08962-7","volume":"21","author":"B Chen","year":"2021","unstructured":"Chen B, Deng T, Deng L, Yu H, He B, Chen K, et al. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma. BMC Cancer. 2021;21(1):1211.","journal-title":"BMC Cancer"},{"issue":"10","key":"5455_CR45","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1158\/1078-0432.CCR-20-3679","volume":"27","author":"E M\u00e4kel\u00e4","year":"2021","unstructured":"M\u00e4kel\u00e4 E, Pavic K, Varila T, Salmenniemi U, L\u00f6yttyniemi E, Nagelli SG. Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias. Clin Cancer Res. 2021;27(10):2848\u201360.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5455_CR46","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s42003-020-01353-x","volume":"3","author":"J Ku","year":"2020","unstructured":"Ku J, Kim R, Kim D, Kim D, Song S, Lee K. Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer. Commun Biol. 2020;3(1):630.","journal-title":"Commun Biol"},{"issue":"4","key":"5455_CR47","doi-asserted-by":"publisher","first-page":"qzaf072","DOI":"10.1093\/gpbjnl\/qzaf072","volume":"23","author":"S Zhang","year":"2025","unstructured":"Zhang S, Chen X, Jin E, Wang A, Chen T, Zhang X, et al. The GSA Family in 2025: A Broadened Sharing Platform for Multi-omics and Multimodal Data. Genom Proteom Bioinform. 2025;23(4):qzaf072.","journal-title":"Genom Proteom Bioinform"},{"issue":"D1","key":"5455_CR48","doi-asserted-by":"publisher","first-page":"D30","DOI":"10.1093\/nar\/gkae978","volume":"53","author":"CNCB-NGDC Members and Partners. Database Resources of the National Genomics Data Center","year":"2025","unstructured":"CNCB-NGDC Members and Partners. Database Resources of the National Genomics Data Center. China National Center for Bioinformation in 2025. Nucleic Acids Res. 2025;53(D1):D30\u201344.","journal-title":"Nucleic Acids Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05455-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05455-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05455-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:04:02Z","timestamp":1782453842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05455-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5455"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05455-6","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human bone marrow blood samples were reviewed and approved by the Medical Institutional Ethics Committee of the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, China. Approval No., (2023) Review No. (143)-KY. Clinical trial number: not applicable. The informed consent to participate was obtained from all of the participants in the study. In addition, all methods in this study were performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All listed authors have actively participated in the study and have read and approved the submitted manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"938"}}